References
Adams JM and
Cory S
(1975)
Modified nucleosides and bizarre 5′‐termini in mouse myeloma mRNA.
Nature
255:
28–33.
Braun JE,
Truffault V,
Boland A et al.
(2012)
A direct interaction between DCP1 and XRN1 couples mRNA decapping to 5′ exonucleolytic degradation.
Nature Structural & Molecular Biology
12:
1324–1331.
Cheng H,
Dufu K,
Lee C‐S et al.
(2006)
Human mRNA export machinery recruited to the 5′ end of mRNA.
Cell
127:
1389–1400.
Chu C and
Shatkin AJ
(2008)
Apoptosis and autophagy induction in mammalian cells by small interfering RNA knockdown of mRNA capping enzymes.
Molecular Cell Biology
19:
5829–5836.
Coller J and
Parker R
(2004)
Eukaryotic mRNA decapping.
Annual Review of Biochemistry
73:
861–890.
Fabian MR and
Sonenberg N
(2012)
The mechanics of miRNA‐mediated gene silencing: a look under the hood of miRISC.
Nature Structural & Molecular Biology
19:
586–593.
Fabian MR,
Sonenberg N and
Filipowicz W
(2010)
Regulation of mRNA translation and stability by microRNAs.
Annual Review of Biochemistry
79:
351–379.
Feoktistova K,
Tuvshintogs E,
Do A and
Fraser CS
(2013)
Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity.
Proceedings of the National Academy of Sciences of the USA
110:
13339–13344.
Filipowicz W,
Furuichi Y,
Sierra JM et al.
(1976)
A protein binding the methylated 5′‐terminal sequence, m7GpppN, of eukaryotic messenger RNA.
Proceedings of the National Academy of Sciences of the USA
73:
1559–1563.
Forrest AR,
Kawaji H,
Rehli M et al.
(2014)
A promotor level mammalian expression atlas.
Nature
507:
462–470.
Furuichi Y
(1974)
“Methylation‐coupled” transcription by virus‐associated transcriptase of cytoplasmic polyhedrosis virus containing double‐stranded RNA.
Nucleic Acids Research
1:
809.
Furuichi Y,
LaFiandra A and
Shatkin AJ
(1977)
5′‐Terminal structure and mRNA stability.
Nature
266:
235–239.
Furuichi Y and
Miura K
(1975)
A blocked structure at the 5′ terminus of mRNA from cytoplasmic polyhedrosis virus.
Nature
253:
374–375.
Furuichi Y,
Morgan M,
Muthukrishnan S and
Shatkin AJ
(1975a)
Reovirus messenger RNA contains a methylated, blocked 5′‐terminal structure: m‐7G(5′)ppp(5′)G‐MpCp‐.
Proceedings of the National Academy of Sciences of the USA
72:
362–366.
Furuichi Y,
Morgan M,
Shatkin AJ et al.
(1975b)
Methylated, blocked 5 termini in HeLa cell mRNA.
Proceedings of the National Academy of Sciences of the USA
72:
1904–1908.
Furuichi Y,
Muthukrishnan S,
Tomasz J and
Shatkin AJ
(1976)
Mechanism of formation of reovirus mRNA 5′‐terminal blocked and methylated sequence, m7GpppGmpC.
Journal of Biological Chemistry
251:
5043–5053.
Furuichi Y and
Shatkin AJ
(2000)
Viral and cellular mRNA capping: past and prospects.
Advances in Virus Research
55:
135–184.
Furuichi Y,
Shatkin AJ,
Stavnezer E and
Bishop JM
(1975c)
Blocked, methylated 5′‐terminal sequence in avian sarcoma virus RNA.
Nature
257:
618–620.
Gingras A‐C,
Raught B and
Sonenberg N
(1999)
elF4 Initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.
Annual Review of Biochemistry
68:
913–963.
Gonatopoulos‐Pournatzis T and
Cowling VH
(2014)
Cap‐ binding complex (CBC).
Biochemical Journal
457:
231–242.
Gupta KC and
Roy P
(1981)
Stimulation of transcription by S‐adenosyl‐L‐homocysteine and virion‐encapsidated methyl donor in spring viraemia of carp virus.
Journal of General Virology
53:
183–187.
Humphreys DT,
Westman BJ,
Martin DI and
Preiss T
(2005)
MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function.
Proceedings of the National Academy of Sciences of the USA
102:
16961–16966.
Kanamori‐Katayama M,
Itoh M,
Kawaji H et al.
(2011)
Unamplified cap analysis of gene expression on a single‐molecule sequencer.
Genome Research
21:
1150–1159.
Kozak M
(1978)
How do eukaryotic ribosomes select initiation regions in messenger RNA?
Cell
15:
1109–1123.
Kozak M
(1989)
The scanning model for translation: an update.
Cell Biology
108:
229–241.
Krug RM
(1989)
The Influenza Viruses.
NewYork, NY: Plenum Press.
Lee AS,
Burdeinick‐Kerr R and
Whelan SP
(2013)
A ribosome‐specialized translation initiation pathway is required for cap‐dependent translation of vesicular stomatitis virus mRNAs.
Proceedings of the National Academy of Sciences of the USA
110:
324–329.
Lewis JD and
Izaurralde E
(1997)
The role of the cap structure in RNA processing and nuclear export.
European Journal of Biochemistry
247:
461–469.
Maquat LE,
Hwang J,
Sato H and
Tang Y
(2010)
CBP80‐promoted mRNP rearrangements during the pioneer round of translation, nonsense‐mediated mRNA decay, and thereafter.
Cold Spring Harbor Symposia on Quantitative Biology
75:
127–134.
Martineau Y,
Azar R,
Bousquet C and
Pyronnet S
(2013)
Anti‐oncogenic potential of the eIF4E‐binding proteins.
Oncogene
32:
671–677.
Maruyama K and
Sugano S
(1994)
Oligo‐capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.
Gene
138:
171–174.
Mathonnet G,
Fabian MR,
Svitkin YV et al.
(2007)
MicroRNA inhibition of translation initiation in vitro by targeting the cap‐binding complex eIF4F.
Science
317:
1764–1767.
Miura K,
Watanabe K and
Sugiura M
(1974)
5′‐Terminal nucleotide sequences of the double‐stranded RNA of silkworm cytoplasmic polyhedrosis virus.
Journal of Molecular Biology
86:
31–48.
Nagarajan VK,
Jones CI,
Newbury SF and
Green PJ
(2013)
XRN 5′→3′ exoribonucleases: structure, mechanisms and functions.
Biochimica et Biophysica Acta
1829:
590–603.
Nuss DL,
Furuichi Y,
Koch G and
Shatkin AJ
(1975)
Detection in HeLa cell extracts of a 7‐methyl guanosine specific enzyme activity that cleaves m7GpppNm.
Cell
6:
21–27.
Ogino T,
Yadav SP and
Banerjee AK
(2010)
Histidine‐mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase.
Proceedings of the National Academy of Sciences of the USA
107:
3463–3468.
Otsuka Y,
Kedersha NL and
Schoenberg DR
(2009)
Identification of a cytoplasmic complex that adds a cap onto 5′‐monophosphate RNA.
Molecular Cell Biology
29:
2155–2167.
Parrish S,
Resch W and
Moss B
(2007)
Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression.
Proceedings of the National Academy of Sciences of the USA
104:
2139–2144
Pillutla RC,
Shimamoto A,
Furuichi Y and
Shatkin AJ
(1998)
Human mRNA capping enzyme (RNGTT) and cap methyltransferase (RNMT) map to 6q16 and 18p11.22‐p11.23, respectively.
Genomics
54:
351–353.
Ricci EP,
Limousin T,
Soto‐Rifo R et al.
(2013)
miRNA repression of translation in vitro takes place during 43S ribosomal scanning.
Nucleic Acids Research
41:
586–598.
Richter JD and
Sonenberg N
(2005)
Regulation of cap‐dependent translation by eIF4E inhibitory proteins.
Nature
433:
477–480.
Shatkin AJ
(1976)
Capping of eucaryotic mRNAs.
Cell
9:
645–653.
Shuman S
(2001)
Structure, mechanism and evolution of the mRNA capping apparatus.
Progress in Nucleic Acid Research and Molecular Biology
66:
1–40.
Sonenberg N and
Hinnebusch AG
(2009)
Regulation of translation initiation in eukaryotes: mechanisms and biological targets.
Cell
136:
731–745.
Sonenberg N,
Morgan MA,
Merrick WC and
Shatkin AJ
(1978)
A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5′‐terminal cap in mRNA.
Proceedings of the National Academy of Sciences of the USA
75:
4843–4847.
Standart N and
Jackson RJ
(2007)
MicroRNAs repress translation of m7Gppp‐capped target mRNAs in vitro by inhibiting initiation and promoting deadenylation.
Genes & Development
21:
1975–1982.
Suzuki Y and
Sugano S
(2003)
Construction of a full‐length enriched and 5′‐end enriched cDNA library using the oligo capping method.
Methods in Molecular Biology
221:
73–91.
Topisirovic I,
Svitkin YV,
Sonenberg N and
Shatkin AJ
(2010)
Cap and cap‐binding proteins in the control of gene expression.
Wiley Interdisciplinary Reviews: RNA
2:
277–298.
Wang Z,
Jiao X,
Carr‐Schmid A and
Kiledjian M
(2002)
The hDcp2 protein is a mammalian mRNA decapping enzyme.
Proceedings of the National Academy of Sciences of the USA
99:
12663–12668.
Yamabe Y,
Sugimoto M,
Satoh M et al.
(1997)
Down‐regulation of the defective transcripts of the Werner's syndrome gene in the cells of patients.
Biochemical and Biophysical Research Communications
236:
1
Further Reading
Anderson R,
Gebhard C,
Miguel‐Escalada I et al.
(2014)
An atlas of active enhancers across human cell types and tissues.
Nature
507:
455–461.
Furuichi Y
(1981)
Allosteric stimulatory effect of S‐adenosylmethionine on the RNA polymerase in cytoplasmic polyhedrosis virus. A model for the positive control of eukaryotic transcription.
Journal of Biological Chemistry
256:
483–493.
Holcik M and
Sonenberg N
(2005)
Translational control in stress and apoptosis.
Nature Reviews Molecular Cell Biology
6:
318–327.
Huntzinger E,
Kuzuoglu‐Öztürk D,
Braun JE et al.
(2013)
The interactions of GW182 proteins with PABP and deadenylases are required for both translational repression and degradation of miRNA targets.
Nucleic Acids Research
41:
978–994.
Liu H and
Kiledjian M
(2006)
Decapping the message: a beginning or an end.
Biochemical Society Transactions
34:
35–38.
Meijer HA,
Kong YW,
Lu WT et al.
(2013)
Translational repression and eIF4A2 activity are critical for microRNA‐mediated gene regulation.
Science
340:
82–85.
Popp MW and
Maquat LE
(2013)
Organizing principles of mammalian nonsense‐mediated mRNA decay.
Annual Review of Genetics
47:
139–165.
Valencia‐Sanchez MA,
Liu J,
Hannon GJ and
Parker R
(2006)
Control of translation and mRNA degradation by miRNAs and siRNAs.
Genes and Development
20:
515–524.
Wahl MC,
Will CL and
Luhrmann R
(2009)
The splicesome: design principles of a dynamic RNP machine.
Cell
136:
701–718.